Viva Physicians Inc
Public records show a registered, tax-exempt organization in good standing.
What it says it does
TO SYNERGIZE THE COLLECTIVE TALENTS OF THESE RECOGNIZED EXPERTS TO PROMOTE AWARENESS AND INNOVATIVE THERAPEUTIC OPTIONS FOR VASCULAR DISEASE
- Income
- $6.9 million
- Spending
- $5.7 million
- Spent on programs
- 93%
- Reserves
- 57.6 months of spending
- Largest source of income
- fees for its services, 56%
- Employees
- 7
- Volunteers
- 0
- Highest pay
- $454,897, executive director
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Strong: 100 out of 100. Higher than 91% of charities in its peer group (education, $1m to $10m).
Reserves
35 of 35Spendable reserves would cover 57.6 months of spending.
Debt
20 of 20It owes 5% of what it owns.
Living within its means
15 of 15Income exceeded spending by 17% of income.
Income trend
15 of 15Income rose 9% on the year before.
Spending floor
15 of 1593% of spending went to programs and raising each dollar of donations cost 1 cents.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Good: 80 out of 100. Higher than 38% of charities in its peer group (education, $1m to $10m).
Independent board
5 of 250 of 12 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
10 of 10Gave the board a copy of this return before filing it.
Pay set independently
5 of 5Sets its chief executive's pay through independent review and comparison.
Independent check of accounts
15 of 15Its accounts were audited by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (1)
- $5.4 million spent. EDUCATIONTHE ORGANIZATION SPONSORS VASCULAR INTERVENTIONAL ADVANCES ("VIVA"), THE GLOBAL EDUCATION COURSE FOR VASCULAR MEDICINE AND INTERVENTION. VIVA IS CONDUCTED ANNUALLY IN LAS VEGAS, NEVADA AND ON A SMALLER SCALE WITH OTHER NONPROFIT ORGANIZATIONS IN A COLLABORATIVE ROLE BOTH DOMESTICALLY AND WORLDWIDE. IN 2025, THE ANNUAL CONFERENCE WAS HOSTED LIVE AND VIRTUALLY, AND SEVERAL EDUCATIONAL WEBINARS WERE HELD THROUGHOUT THE YEAR.VIVA IS SPONSORED BY VPI AND CONTRACTS WITH AN ACCREDITED CONTINUING MEDICAL EDUCATION ("CME") PROVIDER (CONTINUED ON SCHEDULE O)TO APPROVE CREDITS FOR PHYSICIAN ATTENDEES NURSES, TECHS, AND OTHER HEALTHCARE PROFESSIONALS. VIVA FURTHERS VPL'S EXEMPT PURPOSE AS BOTH AN ACCREDITED CONTINUING MEDICAL EDUCATION PROGRAM AND A FORUM FOR PROMOTING THE LATEST RESEARCH FINDINGS AND TECHNOLOGY IN THE FIELD OF VASCULAR MEDICINE AND INTERVENTION.IN 2015, VIVA ADDED A TWO-DAY PROGRAM, THE VEINS (VENOUS ENDOVASCULAR INTERVENTIONAL STRATEGIES), FOCUSED EXCLUSIVELY ON TREATING PATIENTS WITH VENOUS DISEASE. THIS COURSE IS HELD ANNUALLY THE TWO DAYS PRECEDING THE VIVA CONFERENCE. VPI HAS SUPPORTED A MULTIDISCIPLINARY FELLOWSHIP FOR SEVERAL YEARS. IN THE PAST SEVEN YEARS, ADDITIONAL OPPORTUNITIES FOR TRAINING FELLOWS HAVE BEEN INCORPORATED INTO THE ANNUAL VIVA CONFERENCE. BEGINNING IN 2018, VIVA PARTNERED WITH THE AMERICAN HEART ASSOCIATION TO PROVIDE RESEARCH GRANTS FOR FELLOWS AND PLANS TO CONTINUE THIS COLLABORATION THROUGH 2027, AS WELL AS A GRANT FOR A COLLABORATIVE SCIENCES AWARD FOR PATIENT-ORIENTED AND CLINICAL RESEARCH IN VASCULAR SCIENCE.VIVA IS FUNDED PRIMARILY THROUGH UNRESTRICTED EDUCATIONAL GRANTS FROM COMMERCIAL SUPPORTERS IN ACCORDANCE WITH STANDARDS OF THE AMERICAN COUNCIL FOR CONTINUING MEDICAL EDUCATION ("ACCME"). VIVA ALSO GENERATES FUNDS THROUGH REGISTRATION AND TUITION PAYMENTS FROM THE CONFERENCE ATTENDEES.VPI STRIVES TO BE THE PREMIER EDUCATOR IN THE FIELD OF VASCULAR MEDICINE AND INTERVENTION AND TO ASSOCIATE THE NAME "VIVA" WITH CUTTING EDGE AND STATE-OF-THE-ART PROGRAMS THAT SERVE THE PUBLIC GOOD BY PROMOTING ADVANCES IN TREATMENT OF PERIPHERAL VASCULAR DISEASE. IN 2012, VPI EXPANDED ITS INTERNATIONAL EDUCATIONAL OPPORTUNITIES BY COLLABORATING WITH INTERNATIONAL ORGANIZATIONS TO PROVIDE STATE OF THE ART LEARNING MODALITIES AND CUTTING-EDGE PROGRAMS IN COUNTRIES SUCH AS BRAZIL, GERMANY, GREAT BRITAIN, ISRAEL AND CHINA.IN 2014, VPI LAUNCHED A VIRTUAL VIV A APPLICATION THAT MADE IT POSSIBLE FOR INTERNATIONAL AND MILITARY PHYSICIANS TO PARTICIPATE IN THE ANNUAL VIV A CONFERENCE REMOTELY. VIVA OFFERS COMPLIMENTARY ACCESS AND/OR DEEP DISCOUNTS TO EDUCATIONAL CONTENT THROUGH THE VIRTUAL VIVA APP TO INTERNATIONAL PHYSICIANS AS WELL AS ALL ACTIVE MILITARY PHYSICIANS.IN 2025, VPI ENTERED INTO AN AGREEMENT WITH THE MINNEAPOLIS RADIOLOGY AND VASCULAR RESEARCH FOUNDATION TO ASSUME MANAGEMENT OF CARVE - CLINICALLY RELEVANT VASCULAR & ENDOVASCULAR SURGERY, AN EDUCATIONAL CONFERENCE THAT TOOK PLACE FROM MARCH 8, 2026 THROUGH MARCH 11, 2026.RESEARCHVPI SPONSORS RESEARCH AND PIONEERING THERAPY IN THE FIELD OF VASCULAR MEDICINE. VPI RECEIVES GRANTS FROM INDUSTRY AS WELL AS CONTRIBUTIONS FROM PRIVATE INDIVIDUALS IN SUPPORT OF PVD (PERIPHERAL VASCULAR DISEASE) RESEARCH.VPI HAS MANAGED SEVERAL FOOD AND DRUG ADMINISTRATION ("FDA") APPROVED STUDIES RELATED TO PVD TREATMENT. THESE TRIALS FOLLOW GOOD CLINICAL PRACTICE ("GCP") PROTOCOLS AND REQUIRE STRICT INSTITUTIONAL REVIEW BOARD ("IRB") APPROVAL AT EACH SITE. VIVA HAS ALSO PROVIDED SUPPORT FOR NIH APPROVED CLINICAL TRIALS IN THE VASCULAR AND VEINS SPACE.ADVOCACYAS PART OF VPI'S STRATEGIC PLAN, PATIENT CARE ADVOCACY PROGRAMS ARE DESIGNED TO ADVANCE THE FIELD OF VASCULAR DISEASE CARE AND ENGAGE THOUGHT LEADERS AND GOVERNMENT AGENCIES, INCLUDING THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND THE CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS).THE FIRST ADVOCACY PROGRAM WAS HELD IN APRIL 2016 AND FOCUSED ON THE GLOBAL MANAGEMENT OF CRITICAL LIMB ISCHEMIA (CLI), ONE OF THE MOST CHALLENGING VASCULAR DISORDERS. A SECOND VASCULAR DISEASE FORUM WAS CONVENED IN MAY 2018, FOCUSING ON THE TREATMENT AND MANAGEMENT OF CAROTID ARTERY DISEASE. A SUBSEQUENT FORUM IN FEBRUARY 2019 ADDRESSED A META-ANALYSIS EVALUATING THE SAFETY OF PACLITAXEL. AS PART OF THIS EFFORT, VPI LED THE ANALYSIS OF PATIENT-LEVEL DATA TO ADDRESS QUESTIONS RELATED TO PATIENT SAFETY; THE FINDINGS WERE SUBSEQUENTLY PUBLISHED IN THE PEER-REVIEWED JOURNAL CIRCULATION.IN 2022, VPI SPONSORED AN ADDITIONAL FORUM ADDRESSING KEY ISSUES RELATED TO VENOUS STENTING AND THROMBECTOMY, WHICH RESULTED IN A PUBLISHED PAPER. IN 2024, VPI HOSTED A VASCULAR LEADERS FORUM FOCUSED ON CHRONIC LIMBTHREATENING ISCHEMIA (CLTI), WHICH PRODUCED TWO PUBLISHED ARTICLES: COLLABORATION IN CONTEMPORARY CLTI CARE AND DESIGNING CLTI CLINICAL TRIALS.THE 2025 FORUM FOCUSED ON ENDOVASCULAR REPAIR FOR AORTIC ANEURYSMS, WITH TWO WHITE PAPERS EXPECTED TO BE PUBLISHED: (1) A PAPER ADDRESSING THE HISTORY AND TERMINOLOGY SURROUNDING "ENDOLEAK, AND (2) A PAPER FOCUSED ON ADVANCING TREATMENT APPROACHES IN THE COMPLEX AORTIC DISEASE SPACE.
Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated November 6, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2025.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since September 2006.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated November 4, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.